Advertisement

November 28, 2022

Approaches to the Assessment of Clinical Benefit of Treatments for Conditions that Have Heterogeneous Symptoms and Impacts: Potential Applications in Rare Disease

  • Lindsey T. Murray,
  • Timothy A. Howell,
  • Louis S. Matza,
  • ...
  • Dylan Trundell,
  • Stephen J. Coons
  • on behalf of the Rare Disease Subcommittee of the Patient-Reported Outcome Consortium
Published online: November 28, 2022

November 25, 2022

Cost-effectiveness of respiratory syncytial virus preventive interventions in children: a model comparison study

  • Xiao Li,
  • David Hodgson,
  • Julien Flaig,
  • Alexia Kieffer,
  • William L. Herring,
  • Hadi Beyhaghi,
  • Lander Willem,
  • Mark Jit,
  • Joke Bilcke,
  • Philippe Beutels,
  • Harish Nair,
  • Harry Campbell,
  • Andrew Pollard,
  • Peter Openshaw,
  • Federico Martinon-Torres,
  • Terho Heikkinen,
  • Adam Meijer,
  • Thea K. Fischer,
  • Maarten van den Berge,
  • Carlo Giaquinto,
  • Michael Abram,
  • Kena Swanson,
  • Bishoy Rizkalla,
  • Charlotte Vernhes,
  • Scott Gallichan,
  • Jeroen Aerssens,
  • Veena Kumar,
  • Eva Molero
Published online: November 25, 2022

November 24, 2022

Lost therapeutic benefit of delayed LDL-C control in statin treated patients and cost-effectiveness analysis of lipid-lowering intensification

  • Clara Marquina,
  • Jedidiah Morton,
  • Ella Zomer,
  • ...
  • David Thomson,
  • Danny Liew,
  • Zanfina Ademi
Published online: November 24, 2022

One-year temporal changes in long COVID prevalence and characteristics: a systematic review and meta-analysis

  • Qiangru Huang,
  • Mengmeng Jia,
  • Yanxia Sun,
  • ...
  • Dan Cui,
  • Luzhao Feng,
  • Weizhong Yang
Published online: November 24, 2022

Comparisons in the health and economic assessments of using quadrivalent versus trivalent influenza vaccines: a systematic literature review

  • Clara R. Warmath,
  • Ismael R. Ortega-Sanchez,
  • Lindsey M. Duca,
  • ...
  • Joseph S. Bresee,
  • Kathryn E. Lafond,
  • William W. Davis
Published online: November 24, 2022
Open Access

The Use of Multi-Criteria Decision Analysis (MCDA) to Support Decision-Making in Healthcare: an Updated Systematic Literature Review

  • Pamela Gongora-Salazar,
  • Melvin Obadha,
  • Stephen Rocks,
  • Patrick Fahr,
  • Oliver Rivero-Arias,
  • Apostolos Tsiachristas
Published online: November 24, 2022
Open Access

Between-hospital and -physician variation in outcomes and costs in high- and low-complex surgery: A nationwide multi-level analysis

  • N. Salet,
  • V.A. Stangenberger,
  • R.H. Bremmer,
  • F. Eijkenaar
Published online: November 24, 2022
Open Access

November 14, 2022

Measuring Health and Well-Being: We Need to Get it Right for Patients With Patients

  • Eleanor M. Perfetto,
  • Laurie Burke,
  • T. Rosie Love,
  • M. Suz Schrandt,
  • Jeremy Hobart
Published online: November 14, 2022

Modeling tiered pricing frameworks: a simulation approach

  • Javad Moradpour,
  • Wei Zhang,
  • Paul Grootendorst,
  • Aslam H. Anis,
  • Aidan Hollis
Published online: November 14, 2022

November 12, 2022

Developing Prioritization Criteria to Identify Target Drugs for CalRx, the California Generic Drugs Initiative

  • Mariana P. Socal,
  • Emily Estus,
  • Jingmiao Long,
  • Matthew A. Crane,
  • Vishaal Pegany,
  • Gerard F. Anderson
Published online: November 12, 2022

November 11, 2022

Cost-Effectiveness of Medication Therapy Management Program Across Racial and Ethnic Groups Among Medicare Beneficiaries

  • Chi Chun Steve Tsang,
  • Ya-Chen Tina Shih,
  • Xiaobei Dong,
  • ...
  • William C. Cushman,
  • Rose Zeng,
  • Junling Wang
Published online: November 11, 2022

November 10, 2022

Author Reply

  • John Brazier,
  • Tessa Peasgood,
  • Clara Mukuria,
  • ...
  • Federico Augustovski,
  • Wolfgang Greiner,
  • Lidia Engel
Published online: November 10, 2022

November 8, 2022

November 3, 2022

November 1, 2022

October 31, 2022

Pneumococcal Vaccination in Children: A Systematic Review and Meta-Analysis of Cost-effectiveness Studies

  • M. Sakil Syeed,
  • Priyanka Ghule,
  • Lan Le,
  • ...
  • Matt Wasserman,
  • Ammarin Thakkinstian,
  • Nathorn Chaiyakunapruk
Published online: October 31, 2022
Open Access

Health and economic evaluation of vaccination against pertussis in China: a 40-year analysis

  • Dan Wu,
  • Rize Jing,
  • Hui Zheng,
  • ...
  • Wenzhou Yu,
  • Zundong Yin,
  • Hai Fang
Published online: October 31, 2022

Patient-Reported Satisfaction, Experiences, and Preferences: Same but Different?

  • Axel Mühlbacher,
  • Elly Stolk
Published online: October 31, 2022

October 30, 2022

Do Misconceptions about Health-Related Quality of Life Affect General Population Valuations of Health States?

  • Robert P. Murphy,
  • Christopher J. Boyce,
  • Paul Dolan,
  • Gordon D.A. Brown,
  • Alex M. Wood
Published online: October 30, 2022

INTERACTION EFFECTS IN HEALTH STATE VALUATION STUDIES: AN OPTIMAL SCALING APPROACH

  • Marcel F. Jonker,
  • Bas Donkers
Published online: October 30, 2022
Open Access

October 29, 2022

Analyzing Pragmatic Trials to Inform Cost-Effectiveness Analyses

  • David W. Dowdy,
  • Ryan R. Thompson,
  • Alex Kityamuwesi,
  • ...
  • Adithya Cattamanchi,
  • Achilles Katamba,
  • Hojoon Sohn
Published online: October 29, 2022

October 25, 2022

Estimating Joint Health State Utility Algorithms Under Partial Information

  • Jeremy W. Bray,
  • Benjamin D. Thornburg,
  • Abraham W. Gebreselassie,
  • Collin A. LaButte,
  • Carolina Barbosa,
  • Eve Wittenberg
Published online: October 25, 2022
Open Access

October 17, 2022

Using Multiple Authorized Generics to Maintain High Prices: The Example of Entacapone

  • Benjamin N. Rome,
  • Alexander C. Egilman,
  • Neeraj G. Patel,
  • Aaron S. Kesselheim
Published online: October 17, 2022

October 14, 2022

Dealing With Uncertainty in Early Health Technology Assessment: An Exploration of Methods for Decision Making Under Deep Uncertainty

  • Mirre Scholte,
  • Vincent A.W.J. Marchau,
  • Jan H. Kwakkel,
  • Catharina J.M. Klijn,
  • Maroeska M. Rovers,
  • Janneke P.C. Grutters
Published online: October 14, 2022
Open Access

October 13, 2022

Modifying the Composite Time Trade-Off Method to Improve Its Discriminatory Power

  • Michał Jakubczyk,
  • Stefan A. Lipman,
  • Bram Roudijk,
  • ...
  • Yaling Yang,
  • Ning Yan Gu,
  • Elly Stolk
Published online: October 13, 2022
Open Access

October 10, 2022

Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib

  • Simone Huygens,
  • Heleen Vellekoop,
  • Matthijs Versteegh,
  • ...
  • Sarah Wordsworth,
  • Maureen Rutten-van Mölken
  • on behalf of the HEcoPerMed Consortium
Published online: October 10, 2022
Open Access

October 8, 2022

The Impact of Reimbursement for Non-Face-to-Face Chronic Care Management on Health Utilization Among Patients With Type 2 Diabetes in Louisiana

  • Yixue Shao,
  • Charles Stoecker,
  • Dongzhe Hong,
  • ...
  • Alessandra N. Bazzano,
  • Edmond K. Kabagambe,
  • Lizheng Shi
Published online: October 08, 2022

October 7, 2022

How Much Does the US Public Value Equity in Health? A Systematic Review

  • Sara Khor,
  • Zizi A. Elsisi,
  • Josh J. Carlson
Published online: October 07, 2022

October 6, 2022

October 4, 2022

The Prader-Willi Syndrome Anxiousness and Distress Behaviors Questionnaire: Development and Psychometric Validation

  • Sara P. Cotter,
  • Lauren Schwartz,
  • Theresa V. Strong,
  • Randall H. Bender,
  • Sheri E. Fehnel
Published online: October 04, 2022

October 1, 2022

September 28, 2022

Cost-Effectiveness of a Specialized Breathlessness Service Versus Usual Care for Patients With Advanced Diseases

  • Hildegard Seidl,
  • Michaela Schunk,
  • Lien Le,
  • ...
  • Boglarka Lilla Szentes,
  • Claudia Bausewein,
  • Larissa Schwarzkopf
Published online: September 28, 2022

September 20, 2022

Is Intention to Treat Still the Gold Standard or Should Health Technology Assessment Agencies Embrace a Broader Estimands Framework?

Insights and Perspectives From the National Institute for Health and Care Excellence and Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen on the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use E9 (R1) Addendum

  • Antonia Morga,
  • Nicholas R. Latimer,
  • Martin Scott,
  • Neil Hawkins,
  • Michael Schlichting,
  • Jixian Wang
Published online: September 20, 2022

September 17, 2022

September 15, 2022

A Scoping Review of the Use of Machine Learning in Health Economics and Outcomes Research: Part 1—Data From Wearable Devices

  • Woojung Lee,
  • Naomi Schwartz,
  • Aasthaa Bansal,
  • ...
  • Noah Hammarlund,
  • Anirban Basu,
  • Beth Devine
Published online: September 15, 2022

September 13, 2022

September 9, 2022

September 2, 2022

August 30, 2022

Preferences for Sexually Transmitted Infection and Cancer Vaccines in the United States and in China

  • Abram L. Wagner,
  • Yihan Lu,
  • Cara B. Janusz,
  • ...
  • Brian Glover,
  • Zhenke Wu,
  • Lisa A. Prosser
Published online: August 30, 2022
Open Access
Advertisement